Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe

MT Newswires Live

06/05

China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.

The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.

The company's shares closed over 1% lower.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2541047603"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2541047603\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2541047603?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-05 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2541047603","market":"sh","top_or_hot":-1,"title":"Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe","media":"MT Newswires Live","content":"<html><body><p> China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.</p><p>The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.</p><p>The company's shares closed over 1% lower.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNortheast Pharmaceutical Gets Nod to Market Antiobiotic in Europe\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-06-05 16:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.</p><p>The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.</p><p>The company's shares closed over 1% lower.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"醫藥製造","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2541047603","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2541047603","pubTimestamp":1749113109,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China's Northeast Pharmaceutical Group  is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.The company's shares closed over 1% lower.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0239":"医药制造","NBN":"东北银行","000597":"东北制药","BK0191":"维生素","BK4211":"区域性银行"},"translate_title":"东北制药获准在欧洲销售抗生素","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NBN":1,"000597":0.9},"content_text":"China's Northeast Pharmaceutical Group (SHE:000597) is now allowed to sell fosfomycin trometamol in Europe after obtaining a Certificate of Suitability from the European Directorate for the Quality of Medicines and HealthCare, according to a Shenzhen bourse on Thursday.The drug is an antibiotic used to treat infections caused by susceptible pathogens, including respiratory tract infections, lower urinary tract infections, and skin and soft tissue infections, the pharmaceutical company said.The company's shares closed over 1% lower.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}